Faculty > Faculty By Appointment > John Frater, MD

Associate Professor, Pathology and Immunology
Peters Building, 3rd Floor, Room 300L
Office: (314) 362-1553
Pub Med Search

Diagnostic Expertise


Clinical Interest

Anatomic and Molecular Pathology - Hematopathology

Selected Publications

Frater JL, Kling CW, Obadiah JM, Gardner LJ, Grosso LE, Resh B, Hurley MY. Histiocytic sarcoma with secondary involvement of the skin and expression of CD1a: evidence of indeterminate cell differentiation?. J Cutan Pathol. 33(6):437-42., 2006 Abstract

Frater JL, Hoover RG, Bernreuter K, Batanian JR. Deletion of MYC and presence of double minutes with MYC amplification in a morphologic acute promyelocytic leukemia-like case lacking RARA rearrangement: could early exclusion of double-minute chromosomes be a prognostic factor?. Cancer Genet Cytogenet. 166(2):139-45., 2006 Abstract

Batanian JR, Bernreuter K, Koslosky L, Frater JL. Coexistence of neocentromeric marker 3q and trisomy 3 in two different tissues in a 3-year-old boy with peripheral T-cell lymphoma: support for a gene dosage effect hypothesis.. Cancer Genet Cytogenet. 170(2):152-157, 2006 Abstract

Frater JL, Batanian JR, O'Connor DM, Grosso LE. Lymphoblastic leukemia with mature B-cell phenotype in infancy. J Pediatr Hematol Oncol. 26(10):672-7., 2004 Abstract

Parmar S, Rundhaugen LM, Boehlke L, Riley M, Nabhan C, Raji A, Frater JL, Tallman MS. Phase II trial of arsenic trioxide in relapsed and refractory acute myeloid leukemia, secondary leukemia and/or newly diagnosed patients at least 65 years old. Leuk Res. 28(9):909-19., 2004 Abstract

Hsi ED, Frater JL. Advances in the diagnosis and classification of chronic lymphoproliferative disorders. Cancer Treat Res. 121:145-65., 2004 Abstract

Frater JL, Tallman MS, Variakojis D, Druker BJ, Resta D, Riley MB, Hrisinko MA, Peterson LC. Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histopathology and correlation with genetic status. Am J Clin Pathol. 119(6):833-41., 2003 Abstract

Prayson RA, Frater JL. Cortical dysplasia in extratemporal lobe intractable epilepsy: a study of 52 cases. Ann Diagn Pathol. 7(3):139-46., 2003 Abstract

Frater JL, Yaseen NR, Peterson LC, Tallman MS, Goolsby CL. Biphenotypic acute leukemia with coexpression of CD79a and markers of myeloid lineage. Arch Pathol Lab Med. 127(3):356-9., 2003 Abstract

Frater JL, Hsi ED. Properties of the mantle cell and mantle cell lymphoma. Curr Opin Hematol. 9(1):56-62., 2002 Abstract

Prayson RA, Frater JL. Rasmussen encephalitis: a clinicopathologic and immunohistochemical study of seven patients. Am J Clin Pathol. 117(5):776-82., 2002 Abstract

Frater JL, McCarron KF, Hammel JP, Shapiro JL, Miller ML, Tubbs RR, Pettay J, Hsi ED. Typical and atypical chronic lymphocytic leukemia differ clinically and immunophenotypically. Am J Clin Pathol. 116(5):655-64., 2001 Abstract

Frater JL, Hall GS, Procop GW. Histologic features of zygomycosis: emphasis on perineural invasion and fungal morphology. Arch Pathol Lab Med. 125(3):375-8., 2001 Abstract

Frater JL, Prayson RA, Morris III HH, Bingaman WE. Surgical pathologic findings of extratemporal-based intractable epilepsy: a study of 133 consecutive resections. Arch Pathol Lab Med. 124(4):545-9., 2001 Abstract

Frater JL, Tsiftsakis EK, Hsi ED, Pettay J, Tubbs RR. Use of novel t(11;14) and t(14;18) dual-fusion fluorescence in situ hybridization probes in the differential diagnosis of lymphomas of small lymphocytes. Diagn Mol Pathol. 10(4):214-22., 2001 Abstract

Prayson RA, Bingaman W, Frater JL, Wyllie E. Histopathologic findings in 37 cases of functional hemispherectomy. Ann Diagn Pathol. 3(4):205-12., 1999 Abstract